These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17508138)

  • 21. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
    Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between family history of dementia and hallucinations in Parkinson disease.
    Paleacu D; Schechtman E; Inzelberg R
    Neurology; 2005 May; 64(10):1712-5. PubMed ID: 15911796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.
    Hubble JP; Kurth JH; Glatt SL; Kurth MC; Schellenberg GD; Hassanein RE; Lieberman A; Koller WC
    Neuroepidemiology; 1998; 17(2):96-104. PubMed ID: 9592786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders.
    Louis ED; Tang MX; Schupf N
    Mov Disord; 2010 Jan; 25(2):172-8. PubMed ID: 20077482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia in Parkinson's disease: Is male gender a risk factor?
    Cereda E; Cilia R; Klersy C; Siri C; Pozzi B; Reali E; Colombo A; Zecchinelli AL; Mariani CB; Tesei S; Canesi M; Sacilotto G; Meucci N; Zini M; Isaias IU; Barichella M; Cassani E; Goldwurm S; Pezzoli G
    Parkinsonism Relat Disord; 2016 May; 26():67-72. PubMed ID: 26952697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.
    Melton LJ; Leibson CL; Achenbach SJ; Bower JH; Maraganore DM; Oberg AL; Rocca WA
    Mov Disord; 2006 Sep; 21(9):1361-7. PubMed ID: 16703587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of incident dementia in essential tremor: a population-based study.
    Bermejo-Pareja F; Louis ED; Benito-León J;
    Mov Disord; 2007 Aug; 22(11):1573-80. PubMed ID: 17516478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.
    Tatemichi TK; Paik M; Bagiella E; Desmond DW; Stern Y; Sano M; Hauser WA; Mayeux R
    Neurology; 1994 Oct; 44(10):1885-91. PubMed ID: 7936242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Risk Factors and Cognition in Parkinson's Disease.
    Pilotto A; Turrone R; Liepelt-Scarfone I; Bianchi M; Poli L; Borroni B; Alberici A; Premi E; Formenti A; Bigni B; Cosseddu M; Cottini E; Berg D; Padovani A
    J Alzheimers Dis; 2016; 51(2):563-70. PubMed ID: 26890741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.
    Rocca WA; Bower JH; Ahlskog JE; Elbaz A; Grossardt BR; McDonnell SK; Schaid DJ; Maraganore DM
    Arch Neurol; 2007 Oct; 64(10):1458-64. PubMed ID: 17923629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of dementia associated with Parkinson disease.
    Aarsland D; Kurz MW
    J Neurol Sci; 2010 Feb; 289(1-2):18-22. PubMed ID: 19733364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prevalence of Parkinson's disease, associated dementia, and depression in Dresden].
    Riedel O; Schneider C; Klotsche J; Reichmann H; Storch A; Wittchen HU
    Fortschr Neurol Psychiatr; 2013 Feb; 81(2):81-7. PubMed ID: 23412959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
    Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
    Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
    Zhu K; van Hilten JJ; Putter H; Marinus J
    Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of incident dementia with mortality in PD.
    Levy G; Tang MX; Louis ED; Côté LJ; Alfaro B; Mejia H; Stern Y; Marder K
    Neurology; 2002 Dec; 59(11):1708-13. PubMed ID: 12473757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.